Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy.
暂无分享,去创建一个
Yusuke Inoue | Yukihiro Nomura | Kuni Ohtomo | Arinobu Tojo | K. Ohtomo | Y. Nomura | A. Tojo | N. Oyaizu | Kiyoko Izawa | Rieko Sekine | Naoki Oyaizu | Y. Inoue | K. Izawa | Rieko Sekine
[1] C. Scatena,et al. Imaging of bioluminescent LNCaP‐luc‐M6 Tumors: A new animal model for the study of metastatic human prostate cancer , 2004, The Prostate.
[2] Peter Choyke,et al. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. , 2003, BioTechniques.
[3] T Haishi,et al. Development of a 1.0 T MR microscope using a Nd-Fe-B permanent magnet. , 2001, Magnetic resonance imaging.
[4] K. Ohtomo,et al. Light Emission Requires Exposure to the Atmosphere in Ex Vivo Bioluminescence Imaging , 2006, Molecular imaging.
[5] H. Carlsen,et al. In Vivo Imaging of NF-κB Activity1 , 2002, The Journal of Immunology.
[6] A. Poeppl,et al. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] E. Copelan,et al. The biology and treatment of acute lymphoblastic leukemia in adults. , 1995, Blood.
[8] Donna Neuberg,et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. , 2005, Cancer cell.
[9] D. Jenkins,et al. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis , 2004, Clinical & Experimental Metastasis.
[10] Ning Lin,et al. Noninvasive Bioluminescence Imaging of Luciferase Expressing Intracranial U87 Xenografts: Correlation with Magnetic Resonance Imaging Determined Tumor Volume and Longitudinal Use in Assessing Tumor Growth and Antiangiogenic Treatment Effect , 2006, Neurosurgery.
[11] E. Galun,et al. Imaging transgene expression in live animals. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] N. Rubio,et al. Combined Noninvasive Imaging and Luminometric Quantification of Luciferase-Labeled Human Prostate Tumors and Metastases , 2002, Laboratory Investigation.
[13] Christopher H Contag,et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. , 2003, Blood.
[14] S. Chen‐Kiang,et al. Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] Daniel E. Hall,et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. , 2000, Neoplasia.
[16] M. Bailey,et al. Evolution of beetle bioluminescence: the origin of beetle luciferin. , 2004, Luminescence : the journal of biological and chemical luminescence.
[17] S. Kimura,et al. Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models. , 2005, Cancer letters.
[18] F. Stewart,et al. In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats , 2004, British Journal of Cancer.
[19] K. Ohtomo,et al. Imaging living mice using a 1‐T compact MRI system , 2006, Journal of magnetic resonance imaging : JMRI.
[20] Z Symon,et al. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model , 2002, Gene Therapy.
[21] C. Compton,et al. Enhancement of tumor‐liver contrast‐to‐noise ratio with gadobenate dimeglumine in MR imaging of rats , 1993, Journal of magnetic resonance imaging : JMRI.
[22] Z. Paroo,et al. Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. , 2004, Molecular imaging.
[23] Yusuke Inoue,et al. In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[24] Young Kon Kim,et al. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions , 2004, European Radiology.
[25] B. Rice,et al. In vivo imaging of light-emitting probes. , 2001, Journal of biomedical optics.
[26] M. W. Flye,et al. MRI measurement of liver regeneration in mice following partial hepatectomy , 2004, Magnetic resonance in medicine.
[27] W. Schima,et al. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications , 2004, European Radiology.
[28] Sheng-Kwei Song,et al. MRI Detection of Early Bone Metastases in B16 Mouse Melanoma Models , 2005, Clinical & Experimental Metastasis.
[29] C. Contag,et al. Use of reporter genes for optical measurements of neoplastic disease in vivo. , 2000, Neoplasia.
[30] F. Blankenberg,et al. Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. , 2004, Molecular imaging.
[31] Ping Chen,et al. Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor , 2004, Science.
[32] George Q. Daley,et al. The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity , 1999, The Journal of experimental medicine.
[33] Daniel Candinas,et al. Magnetic resonance imaging provides accurate and precise volume determination of the regenerating mouse liver , 2004, Journal of Gastrointestinal Surgery.
[34] I. B. Borel Rinkes,et al. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. , 2004, The Journal of surgical research.
[35] C. Contag,et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. , 2002, European journal of cancer.
[36] R A Moats,et al. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. , 2003, BioTechniques.